Entry Name Choline metabolism in cancer - Hipposideros armiger (great roundleaf bat)
Description Abnormal choline metabolism is emerging as a metabolic hallmark that is associated with oncogenesis and tumour progression. Following transformation, oncogenic signalling via pathways such as the RAS and PI3K-AKT pathways, and transcription factors associated with oncogenesis such as hypoxia-inducible factor 1 (HIF1) mediate overexpression and activation of choline cycle enzymes, which causes increased levels of choline-containing precursors and breakdown products of membrane phospholipids. These products of choline phospholipid metabolism, such as phosphocholine (PCho), diacylglycerol (DAG) and phosphatidic acid, may function as second messengers that are essential for the mitogenic activity of growth factors, particularly in the activation of the ras-raf-1-MAPK cascade and protein kinase C pathway.
Class Human Diseases; Cancer: overviewBRITE hierarchy
Pathway map Ortholog table Organism Hipposideros armiger (great roundleaf bat) [GN:
hai ]
Gene 109392273 PDGFB; platelet-derived growth factor subunit B isoform X1 [KO:K17386 ]
109383688 GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364 ]
109382359 RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732 ]
109381238 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922 ] [EC:2.7.1.153 ]
109394108 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
109372681 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
109382484 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
109395865 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
109373811 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
109393572 EIF4EBP1; eukaryotic translation initiation factor 4E-binding protein 1 [KO:K07205 ]
109393041 RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861 ]
109384767 WASF1; wiskott-Aldrich syndrome protein family member 1 isoform X1 [KO:K05753 ]
109386760 WASF2; wiskott-Aldrich syndrome protein family member 2 [KO:K05748 ]
109387514 WASF3; wiskott-Aldrich syndrome protein family member 3 isoform X1 [KO:K06083 ]
109373465 SLC5A7; high affinity choline transporter 1 isoform X1 [KO:K14387 ]
109383515 SLC44A5; choline transporter-like protein 5 isoform X1 [KO:K15377 ]
109391663 SLC44A2; choline transporter-like protein 2 isoform X1 [KO:K15377 ]
109396410 SLC44A3; choline transporter-like protein 3 isoform X1 [KO:K15282 ]
109379925 PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116 ] [EC:3.1.4.11 ]
Compound C00093 sn-Glycerol 3-phosphate
C00670 sn-Glycero-3-phosphocholine
C04230 1-Acyl-sn-glycero-3-phosphocholine
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference Authors Glunde K, Bhujwalla ZM, Ronen SM
Title Choline metabolism in malignant transformation.
Journal Reference Authors Beloueche-Babari M, Chung YL, Al-Saffar NM, Falck-Miniotis M, Leach MO
Title Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy.
Journal Reference Authors Abalsamo L, Spadaro F, Bozzuto G, Paris L, Cecchetti S, Lugini L, Iorio E, Molinari A, Ramoni C, Podo F
Title Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
Journal Reference Authors Foster DA
Title Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.
Journal Reference Authors Beloueche-Babari M, Jackson LE, Al-Saffar NM, Eccles SA, Raynaud FI, Workman P, Leach MO, Ronen SM
Title Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells.
Journal Reference Authors Ridgway ND
Title The role of phosphatidylcholine and choline metabolites to cell proliferation and survival.
Journal Reference Authors Awwad HM, Geisel J, Obeid R
Title The role of choline in prostate cancer.
Journal Reference Authors Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D'Ascenzo S, Millimaggi D, Pavan A, Dolo V, Canevari S, Podo F
Title Alterations of choline phospholipid metabolism in ovarian tumor progression.
Journal Reference Authors Ackerstaff E, Glunde K, Bhujwalla ZM
Title Choline phospholipid metabolism: a target in cancer cells?
Journal Reference Authors Park JB, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG, Ryu SH
Title Phospholipase signalling networks in cancer.
Journal Reference Authors Yalcin A, Clem B, Makoni S, Clem A, Nelson K, Thornburg J, Siow D, Lane AN, Brock SE, Goswami U, Eaton JW, Telang S, Chesney J
Title Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
Journal Reference Authors Glunde K, Jiang L, Moestue SA, Gribbestad IS
Title MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.
Journal Reference Authors Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA
Title Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
Journal Reference Authors Foster DA, Xu L
Title Phospholipase D in cell proliferation and cancer.
Journal Mol Cancer Res 1:789-800 (2003)
Reference Authors Zhou H, Huang S
Title mTOR signaling in cancer cell motility and tumor metastasis.
Journal Related hai04810 Regulation of actin cytoskeleton
KO pathway LinkDB All DBs
